Home Cart 0 Sign in  

[ CAS No. 62259-92-1 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 62259-92-1
Chemical Structure| 62259-92-1
Structure of 62259-92-1 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 62259-92-1 ]

Related Doc. of [ 62259-92-1 ]

Alternatived Products of [ 62259-92-1 ]

Product Details of [ 62259-92-1 ]

CAS No. :62259-92-1 MDL No. :MFCD22552967
Formula : C15H17N3O Boiling Point : -
Linear Structure Formula :- InChI Key :HSHFWFQDSHKRIT-UHFFFAOYSA-N
M.W : 255.32 Pubchem ID :135553026
Synonyms :

Calculated chemistry of [ 62259-92-1 ]

Physicochemical Properties

Num. heavy atoms : 19
Num. arom. heavy atoms : 12
Fraction Csp3 : 0.33
Num. rotatable bonds : 2
Num. H-bond acceptors : 3.0
Num. H-bond donors : 1.0
Molar Refractivity : 78.55
TPSA : 48.99 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : Yes
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -7.39 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.38
Log Po/w (XLOGP3) : 0.66
Log Po/w (WLOGP) : 0.95
Log Po/w (MLOGP) : 1.68
Log Po/w (SILICOS-IT) : 3.26
Consensus Log Po/w : 1.79

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.17
Solubility : 1.71 mg/ml ; 0.0067 mol/l
Class : Soluble
Log S (Ali) : -1.26
Solubility : 13.9 mg/ml ; 0.0543 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -5.04
Solubility : 0.00233 mg/ml ; 0.00000914 mol/l
Class : Moderately soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 0.0
Synthetic accessibility : 2.55

Safety of [ 62259-92-1 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 62259-92-1 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 62259-92-1 ]
  • Downstream synthetic route of [ 62259-92-1 ]

[ 62259-92-1 ] Synthesis Path-Upstream   1~1

  • 1
  • [ 124-42-5 ]
  • [ 52763-21-0 ]
  • [ 62259-92-1 ]
YieldReaction ConditionsOperation in experiment
95% With sodium methylate In methanol at 25℃; for 20 h; Inert atmosphere General procedure: To a solution of sodium methoxide (25 wt-percent in methanol) (67.6 mL, 296 mmol) and methanol (70 mL) at 25 °C was added formamidine acetate (11.00 g, 106 mmol) and then ethyl N-benzyl-3-oxo-4-piperidine carboxylate hydrochloride (25.16 g, 84 mmol). The resulting mixture was stirred at 25 °C for 20 h. The mixture was cooled to 0 °C. Water (90mL) was added, followed by the dropwise addition of acetic acid (6.05 mL, 106 mmol), and the reaction mixture was stirred at 25 °C for another 3 h. The mixture was reduced in volume under vacuum until most of the methanol had been removed. The suspension was filtered. The solids were washed with water and thendried under vacuum to afford 7-benzyl-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidin-4(3H)-one (16.10 g, 79 percent) as an off-white solid; LC/MS:m/z 242.06 (M + H)+, 0.598 min (method 12). 1H-NMR (500 MHz, CDCl3) δ12.61 (br s, 1 H), 7.99 (s, 1 H), 7.38-7.26 (m, 5 H),3.73 (m, 2 H), 3.50 (m, 2 H), 2.74 (m, 2 H), 2.66 (m, 2 H).
77% With sodium ethanolate In ethanol for 16 h; Heating / reflux Example 51Preparation of Compounds 211, 215, 216, 225, 226 and 231Compounds 211, 215, 216, 225, 226 and 231 were prepared using the method set forth below. <n="193"/>Step A - Synthesis of7-benzyl-2-methyl-5,6, 7,8-tetrahydro-3H-pyrido[3,4-d]pyrimidin-4-oneTo a solution of l-benzyl-3-oxo-piperidine-4-carboxylic acid ethyl ester hydrochloride (5.0 g, 16.8 mmol) in 80 mL ethanol was added acetamidine hydrochloride (2.4 g, 25.2 mmol) followed by sodium ethoxide (21percent in ethanol, 10.6 mL, 33.6 mmol). The resulting reaction was heated to reflux and allowed to stir at this temperature for 16 hours. The reaction was then cooled to room temperature, diluted with dichloromethane, and the organic phase was washed with water and brine, dried and concentrated in vacuo, the resulting residue was purified using flash column chromatography (5percent methanol in dichloromethane) to provide 7-benzyl-2- methyl-5,6,7,8-tetrahydro-3H-pyrido[3,4-d]pyrimidin-4-one in 77percent yield.
95% With sodium ethanolate In ethanol; water; acetic acid Step A:
7-Benzyl-2-methyl-5,6,7,8-tetrahydro-3H-pyrido[3,4-d]pyrimidin-4-one
A solution of sodium ethoxide in ethanol was prepared by addition of sodium metal (5.7 g, 247 mmol) to absolute ethanol (141 mL).
After the sodium metal had all dissolved, ethyl 1-benzyl-3-oxo-4-piperidine carboxylate hydrochloride (21 g, 70.5 mmol) was added followed by acetamidine hydrochloride (13.3 g, 141 mmol).
This mixture was stirred at reflux for 1 h, cooled to room temperature, and concentrated.
The residue was dissolved in a minimum amount of water and the pH was adjusted to about 7 with glacial acetic acid.
The resulting yellow precipitate was filtered, washed with water (3*), air-dried for 2 h, then vacuum-dried overnight to provide 17.1 g (95percent) of the title compound of Example 86, Step A as a yellow solid. 1H NMR (CDCl3, 250 MHz) δ7.35-7.25 (c, 5H), 3.70 (s, 2H), 3.42 (s, 2H), 2.73-2.64 (c, 2H), 64-2.60 (c, 2H), 2.41 (s, 3H); MS (APCI) 256 (MH+).
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2016, vol. 26, # 1, p. 160 - 167
[2] Patent: WO2008/130581, 2008, A1, . Location in patent: Page/Page column 192
[3] Patent: US6414149, 2002, B1,
[4] Patent: WO2008/130581, 2008, A1, . Location in patent: Page/Page column 172
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 62259-92-1 ]

Aryls

Chemical Structure| 62458-96-2

[ 62458-96-2 ]

7-Benzyl-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidin-4(3H)-one

Similarity: 0.91

Chemical Structure| 1290541-46-6

[ 1290541-46-6 ]

(E)-3-Benzyl-2-(2-(pyridin-3-yl)vinyl)quinazolin-4(3H)-one

Similarity: 0.78

Chemical Structure| 109229-22-3

[ 109229-22-3 ]

6-Benzyl-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidin-4(3H)-one

Similarity: 0.78

Chemical Structure| 18184-75-3

[ 18184-75-3 ]

6-Benzyl-5,7-dihydro-5,7-dioxopyrrolo[3,4-b]pyridine

Similarity: 0.71

Chemical Structure| 342417-01-0

[ 342417-01-0 ]

6-(4-Methylpiperazin-1-yl)-4-(o-tolyl)nicotinamide

Similarity: 0.69

Amides

Chemical Structure| 62458-96-2

[ 62458-96-2 ]

7-Benzyl-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidin-4(3H)-one

Similarity: 0.91

Chemical Structure| 1290541-46-6

[ 1290541-46-6 ]

(E)-3-Benzyl-2-(2-(pyridin-3-yl)vinyl)quinazolin-4(3H)-one

Similarity: 0.78

Chemical Structure| 109229-22-3

[ 109229-22-3 ]

6-Benzyl-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidin-4(3H)-one

Similarity: 0.78

Chemical Structure| 1015474-32-4

[ 1015474-32-4 ]

3-(5-Amino-2-methyl-4-oxoquinazolin-3(4H)-yl)piperidine-2,6-dione

Similarity: 0.76

Chemical Structure| 63234-80-0

[ 63234-80-0 ]

3-(2-Chloroethyl)-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one

Similarity: 0.76

Related Parent Nucleus of
[ 62259-92-1 ]

Other Aromatic Heterocycles

Chemical Structure| 62458-96-2

[ 62458-96-2 ]

7-Benzyl-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidin-4(3H)-one

Similarity: 0.91

Chemical Structure| 109229-22-3

[ 109229-22-3 ]

6-Benzyl-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidin-4(3H)-one

Similarity: 0.78

Chemical Structure| 93076-03-0

[ 93076-03-0 ]

3-(2-Chloroethyl)-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one hydrochloride

Similarity: 0.76

Chemical Structure| 63234-80-0

[ 63234-80-0 ]

3-(2-Chloroethyl)-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one

Similarity: 0.76

Chemical Structure| 19178-25-7

[ 19178-25-7 ]

Pyrido[3,4-d]pyrimidin-4(3H)-one

Similarity: 0.75